BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34219892)

  • 21. Can we rely on pathologic parameters to define conservative treatment of papillary thyroid carcinoma?
    Paessler M; Kreisel FH; LiVolsi VA; Akslen LA; Baloch ZW
    Int J Surg Pathol; 2002 Oct; 10(4):267-72. PubMed ID: 12490976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
    Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
    Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implications of microscopic extrathyroidal extension in patients with papillary thyroid carcinoma.
    Park JS; Chang JW; Liu L; Jung SN; Koo BS
    Oral Oncol; 2017 Sep; 72():183-187. PubMed ID: 28222967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas.
    Wong KS; Strickland KC; Angell TE; Nehs MA; Alexander EK; Cibas ES; Krane JF; Howitt BE; Barletta JA
    Endocr Pathol; 2017 Jun; 28(2):171-176. PubMed ID: 28271380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer.
    Youngwirth LM; Adam MA; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 May; 27(5):626-631. PubMed ID: 27597378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT.
    Choi JW; Yoon YH; Yoon YH; Kim SM; Koo BS
    Ann Surg Oncol; 2011 May; 18(5):1306-11. PubMed ID: 21140231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implication of minimal extrathyroidal extension as a prognostic factor in papillary thyroid carcinoma.
    Shin JH; Ha TK; Park HK; Ahn MS; Kim KH; Bae KB; Kim TH; Choi CS; Kim TK; Bae SK; Kim SH
    Int J Surg; 2013; 11(9):944-7. PubMed ID: 23820062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Differentiated thyroid carcinoma: prognostic factors].
    Györy F; Lukács G; Nagy EV; Juhász F; Mezösi E; Szakáll S; Máth J; Balázs G
    Magy Seb; 2001 Apr; 54(2):69-74. PubMed ID: 11339092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
    Sun W; Lan X; Zhang H; Dong W; Wang Z; He L; Zhang T; Liu S
    PLoS One; 2015; 10(10):e0139021. PubMed ID: 26431346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors for central lymph node metastases in CN0 papillary thyroid microcarcinoma (mPTC): A retrospective analysis of 1304 cases.
    Zhang Q; Wang Z; Meng X; Duh QY; Chen G
    Asian J Surg; 2019 Apr; 42(4):571-576. PubMed ID: 30348606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate Thyroid Nodules.
    Valderrabano P; Khazai L; Thompson ZJ; Otto KJ; Hallanger-Johnson JE; Chung CH; Centeno BA; McIver B
    JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):788-795. PubMed ID: 30027226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions.
    Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G
    Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
    Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
    Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and significance of minimal and maximal extrathyroidal extension in papillary thyroid carcinoma.
    Jin BJ; Kim MK; Ji YB; Song CM; Park JH; Tae K
    Oral Oncol; 2015 Aug; 51(8):759-63. PubMed ID: 26093388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive factors for extrathyroidal extension of papillary thyroid carcinoma based on preoperative sonography.
    Lee CY; Kim SJ; Ko KR; Chung KW; Lee JH
    J Ultrasound Med; 2014 Feb; 33(2):231-8. PubMed ID: 24449725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
    Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
    J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extent of surgery did not affect recurrence during 7-years follow-up in papillary thyroid cancer sized 1-4 cm: Preliminary results.
    Kim MJ; Lee MC; Lee GH; Choi HS; Cho SW; Kim SJ; Lee KE; Park YJ; Park DJ
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):80-86. PubMed ID: 28338234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unexpected high-risk pathologic features following thyroidectomy in the chinese immigrant population.
    Badhey AK; Moshier E; Jategaonkar A; Wong A; Echanique K; Chai RL
    Laryngoscope; 2020 Jul; 130(7):1844-1849. PubMed ID: 31593307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity and High Risk Pathological Features of Papillary Thyroid Carcinoma: A Retrospective Analysis of a University Hospital in Pakistan.
    Zaman SU; Awan MS; Sulaiman MA
    Gulf J Oncolog; 2018 May; 1(27):6-10. PubMed ID: 30145545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postsurgical pathology reporting of thyroid cancer in New South Wales, Australia.
    Kahn C; Simonella L; Sywak M; Boyages S; Ung O; O'Connell D
    Thyroid; 2012 Jun; 22(6):604-10. PubMed ID: 22524497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.